1. Home
  2. ASH vs HRMY Comparison

ASH vs HRMY Comparison

Compare ASH & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ashland Inc.

ASH

Ashland Inc.

HOLD

Current Price

$59.28

Market Cap

2.7B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.78

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASH
HRMY
Founded
1924
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ASH
HRMY
Price
$59.28
$37.78
Analyst Decision
Buy
Strong Buy
Analyst Count
8
9
Target Price
$64.29
$51.33
AVG Volume (30 Days)
997.5K
695.1K
Earning Date
01-27-2026
11-04-2025
Dividend Yield
2.78%
N/A
EPS Growth
N/A
50.44
EPS
N/A
3.17
Revenue
$1,824,000,000.00
$825,944,000.00
Revenue This Year
$3.34
$23.11
Revenue Next Year
$3.66
$16.15
P/E Ratio
N/A
$12.04
Revenue Growth
N/A
21.13
52 Week Low
$45.21
$25.52
52 Week High
$73.31
$40.93

Technical Indicators

Market Signals
Indicator
ASH
HRMY
Relative Strength Index (RSI) 61.07 54.65
Support Level $58.66 $37.12
Resistance Level $59.78 $39.60
Average True Range (ATR) 1.55 1.15
MACD -0.27 -0.38
Stochastic Oscillator 47.07 17.33

Price Performance

Historical Comparison
ASH
HRMY

About ASH Ashland Inc.

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: